Trial Profile
The pre-emptive use of pregabalin may reduce the incidence of postmasectomy pain syndrome following breast cancer surgery: a comparitive study
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 03 Oct 2018
Price :
$35
*
At a glance
- Drugs Pregabalin (Primary)
- Indications Neuropathic pain
- Focus Therapeutic Use
- 10 Sep 2018 Planned number of patients changed from 200 to 210.
- 13 Sep 2017 New trial record